Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantationKaren M. Dwyer, Anthony J.F. d’Apice, Elżbieta Kaczmarek et al.|Journal of Clinical Investigation|2004Cited by 183
The Spot Sign and Tranexamic Acid on Preventing ICH Growth – AUStralasia Trial (STOP-AUST): Protocol of a Phase II Randomized, Placebo-Controlled, Double-Blind, Multicenter TrialAtte Meretoja, Stephen M. Davis, Leonid Churilov et al.|International Journal of Stroke|2013Cited by 73
The Transgenic Expression of Human CD39 on Murine Islets Inhibits Clotting of Human BloodKaren M. Dwyer, Anthony J. F. d Apice, Tharun B. Mysore et al.|Transplantation|2006Cited by 69
Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantationKaren M. Dwyer, Anthony J.F. d’Apice, Simon C. Robson et al.|Journal of Clinical Investigation|2004Cited by 50